Sequenom, Inc. (SQNM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Sequenom, Inc. (Sequenom) is a life sciences company which offers genetic testing that guides reproductive health matters. The company operates CAP (College of American Pathologists) accredited and CLIA (Clinical Laboratory Improvements Amendment) certified molecular diagnostics clinical laboratory (MDCL) that specializes in the field of in prenatal health. Sequenom offers wide collection of carrier status, noninvasive prenatal testing, and diagnostic test options ranging from baby’s whole genome assessment to specific conditions identification which allows parents and physicians to select the right test for each pregnancy. The molecular genetic laboratory-developed tests offer early patient management information for geneticists, maternal fetal medicine specialists, and obstetricians as well as patients. Its MDCLs are located at San Diego, California; Raleigh-Durham, North Carolina; and Grand Rapids, Michigan. Sequenom is headquartered in San Diego, California, the US.
Sequenom, Inc. Key Recent Developments
Jun 27, 2016: The Supreme Court Of The United States Denies Sequenom's Petition Requesting Review Of Decision On '540 Patent
May 04, 2016: Sequenom Reports First Quarter 2016 Results
May 03, 2016: Sequenom Announces In-Network Contracts with Anthem Blue Cross and Blue Shield Plans for Georgia, Indiana, Kentucky, Missouri, Ohio, Virginia and Wisconsin
Apr 19, 2016: Sequenom Completes Consolidation of North Carolina Operations
Apr 12, 2016: Sequenom Strengthens Executive Team with New Vice President of Sales
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Sequenom, Inc. - Key Facts 6
Sequenom, Inc. - Key Employees 7
Sequenom, Inc. - Key Employee Biographies 8
Sequenom, Inc. - Major Products and Services 9
Sequenom, Inc. - Medical Equipment Pipeline Products Data 10
Sequenom, Inc. Pipeline Products by Equipment Type 10
Sequenom, Inc. Pipeline Products by Development Stage 11
Sequenom, Inc. - History 13
Sequenom, Inc. - Company Statement 18
Sequenom, Inc. - Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Section 2 – Company Analysis 21
Sequenom, Inc. - Business Description 21
Sequenom, Inc. - Corporate Strategy 22
Sequenom, Inc. - SWOT Analysis 23
SWOT Analysis - Overview 23
Sequenom, Inc. - Strengths 23
Strength - Research and Development Activities 23
Strength - Proprietary MassARRAY System 23
Strength - Strategic Acquisitions 23
Sequenom, Inc. - Weaknesses 25
Weakness - Operating Loss Carryforward 25
Weakness - Declining Cash Reserves 25
Sequenom, Inc. - Opportunities 26
Opportunity - Strategic Initiatives 26
Opportunity - Growing Genetic Testing Market 26
Opportunity - New Product Launches 26
Sequenom, Inc. - Threats 27
Threat - Stringent Government Regulations 27
Threat - Uncertain R&D Outcomes 27
Threat - Competitive Environment 27
Sequenom, Inc. - Key Competitors 28
Section 3 – Company Financial Ratios 29
Financial Ratios - Capital Market Ratios 29
Financial Ratios - Annual Ratios 30
Performance Chart 31
Financial Performance 31
Financial Ratios - Interim Ratios 32
Financial Ratios - Ratio Charts 33
Section 4 – Company’s Lifesciences Financial Deals and Alliances 34
Sequenom, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 34
Sequenom, Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016 35
Sequenom, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 36
Sequenom, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 37
Sequenom, Inc., Recent Deals Summary 38
Section 5 – Company’s Recent Developments 39
May 04, 2016: Sequenom Reports First Quarter 2016 Results 39
May 03, 2016: Sequenom Announces In-Network Contracts with Anthem Blue Cross and Blue Shield Plans for Georgia, Indiana, Kentucky, Missouri, Ohio, Virginia and Wisconsin 41
Apr 19, 2016: Sequenom Completes Consolidation of North Carolina Operations 42
Apr 12, 2016: Sequenom Strengthens Executive Team with New Vice President of Sales 43
Mar 21, 2016: Sequenom Files Petition With the Supreme Court of the United States Requesting Review Of Decision On '540 Patent 44
Mar 02, 2016: Sequenom Reports 2015 Financial Results 45
Mar 02, 2016: Sequenom Announces Contract with Anthem BlueCross 48
Feb 25, 2016: Sequenom Laboratories Announces Positive Results from Clinical Validation Study on the MaterniT GENOME Test 49
Jan 11, 2016: Sequenom Provides Update On MaterniT Genome Test 50
Jan 11, 2016: Sequenom Announces Preliminary 2015 Results 51
Section 6 – Appendix 52
Methodology 52
Ratio Definitions 52
About GlobalData 56
Contact Us 56
Disclaimer 56
List Of Tables
List of Tables
Sequenom, Inc., Key Facts 6
Sequenom, Inc., Key Employees 7
Sequenom, Inc., Key Employee Biographies 8
Sequenom, Inc., Major Products and Services 9
Sequenom, Inc. Pipeline Products by Equipment Type 10
Sequenom, Inc. Number of Pipeline Products by Development Stage 11
Sequenom, Inc. Pipeline Products Summary by Development Stage 12
Sequenom, Inc., History 13
Sequenom, Inc., Other Locations 19
Sequenom, Inc., Subsidiaries 19
Sequenom, Inc., Key Competitors 28
Sequenom, Inc., Ratios based on current share price 29
Sequenom, Inc., Annual Ratios 30
Sequenom, Inc., Interim Ratios 32
Sequenom, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 34
Sequenom, Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016 35
Sequenom, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 36
Sequenom, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 37
Sequenom, Inc., Recent Deals Summary 38
Currency Codes 52
Capital Market Ratios 52
Equity Ratios 53
Profitability Ratios 53
Cost Ratios 54
Liquidity Ratios 54
Leverage Ratios 55
Efficiency Ratios 55
Lisst Of Figures
List of Figures
Sequenom, Inc. Pipeline Products by Equipment Type 10
Sequenom, Inc. Pipeline Products by Development Stage 11
Sequenom, Inc., Performance Chart (2011 - 2015) 31
Sequenom, Inc., Ratio Charts 33
Sequenom, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 34
Sequenom, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 35
Sequenom, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 36
Sequenom, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 37
